You are on page 1of 1

Coverage rate of primary school pupils after mass treatment with praziquantel in Sm1 schools with

schistosomiasis prevalence of 10-24%

Background information Objectives Materials and methods


Schistosomiasis remains a major public health problem in the The study was conducted in 75 primary schools along the Lake
country, especially in the western part of Kenya. To determine coverage rate of primary Victoria region in 5 Districts and Kisumu municipality in Nyanza
Following the advent of safe, inexpensive and efficacious single-dose school pupils after mass treatment with province.
oral drugs, chemotherapy is now considered the cornerstone for School based approach was used where trained health teachers
morbidity control of schistosomiasis targeting school-aged children praziquantel in Sm1 schools with administered treatments to children in their schools by use of a dose
and other high-risk groups (WHO, 2003). schistosomiasis prevalence of 10-24%. pole to determine dosage
School based mass drug administration (MDA) is advocated to With this approach, children received a single dose of praziquantel
reduce morbidity in school aged populations. (40mg/kg body weight) using validated dose pole (WHO,2003)
The success and impact of school based programs is dependent on Enriched porridge was given as supplementary food during treatment
high treatment coverage –WHO recommends 75% treatment coverage to reduce the nauseating effect of praziquantel.
rate.

Results
Bondo District Schools
100%
Rarieda District Schools
90%
80% 100%
70%
60% 98%
50% 96%
40% 94%
30%
20% 92%
10% NI A Y AR A A A
NG AL AN NG OW EY
0% E AS DI ACH IE IG LW
G M A R H M
RA M OC

Kisumu East District Schools


Kisumu North District Schools 100.00%
98.00%
100%
96.00%
50% 94.00%
Kisumu West District Schools 0% 92.00%
100.00% 90.00%
MIGINGO NYAMWARE NDURU
80.00%

60.00%

40.00% Rachuonyo District Schools 100%


100.00% Nyakach District Schools
80.00% 90%
20.00%
60.00%
80%
0.00% 40.00%
I K20.00%
70%
IR O BA
L O G K O N O O O O LA A RI A LA
IS
K IE G PA A ER U D D ER ES Y EI RI O
BA M
CH LU E G D G A O G G BO N
RI A A
CH 0.00% SA M M NG UGO
E O
RA
U A K O
AD
M I M W D W
A SA
O
R
K
O M E Y M K
A A
CH O BA P
N O
A
K M
I N A
L O
KU LU I NA TE B
Y K LI Y
EY O A
J..
. O A A I R A W
N
TH LA N O
K S IM G K GA IG UY UT AK
A RA BU BUG NY
H
PI JO N
BO KO AJ AW OL JI OC
O A OB OJ AK N O KA
OM L M KA
PA

Results and discussions Conclusion and recommendations Authors


Dr. Pauline Mwinzi, Sue Montgomery, Evan Secor, Diana M.S.
Treatment rates varied from 100% to 50.23%; 72 schools achieved Praziquantel treatment coverage to control schistosomiais using school Karanja, Erick Muok, Elizabeth Ochola and Bernard Abudho
based treatment approach resulted in a great treatments of children in
the 75% target set WHO while 3 schools failed to hit the 75% target.
schools as most school achieved the desired 75% treatment coverage. Affiliations
The higher treatment coverage rate observed was probably as a The results of this study suggest that the high treatment coverage rates Neglected Tropical Diseases Branch, Center for Global Health
result of positive interactions between teachers, children, parents and
were observed during these campaigns and should be sustained by a Research, Kenya Medical Research Institute, P.O. Box 1578-40100,
health workers.
yearly chemotherapy strategy preceded by a community's health Kisumu, Kenya Division of Parasitic Diseases, Centers for Disease
School based treatment programmes take the advantage of the education programmes. Control and Prevention, 4770 Buford Highway, N.E. Mail-Stop F-13,
extensive educational infrastructure which provide a system where a
large number of school aged children are reached for MDA(WHO,
Efforts should be made to encourage non enrolled children of school Atlanta, GA; Center for Tropical and Emerging Tropical Diseases
age to show up during treatments. (CTEGD), The University of Georgia Department of Microbiology
2003). 500 D.W. Brooks Drive, Room 145 Coverdell Center Athens,
  Georgia 30602-7399 USA.

E-mail info@ke.cdc.gov
The findings and conclusions in this report are those of the authors and do not
necessarily represent the official position of the Centers for Disease Control and Prevention.

You might also like